Delivery Order SPE2DB20D2104-SPE2DB23FV23L

Award Date 9/7/23
Potential Completion Date 9/8/23
Potential Value $3.6K
Ultimate Awardee
Cencora, Inc.
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The contract was awarded to Amerisourcebergen Drug Corp, a subsidiary of the parent company Cencora, Inc., which is a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed-price pricing type, valued at $2,357.98, and has an ultimate completion date of June 13, 2023. This contract is...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML, a pharmaceutical product, to the Defense Logistics Agency (DLA). The $2,262.17 firm-fixed-price delivery order has an ultimate completion date of April 26, 2024. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, one of the largest pharmaceutical distribution companies in the world. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceuticals to the Defense Logistics Agency (DLA) Troop Support Medical. The award was made to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distribution company Amerisourcebergen Corporation, as a prime contractor. The contract is a firm fixed price delivery order with a ceiling value of $5,545.40 and a performance period through April 2, 2024. Amerisourcebergen Drug Corp holds an...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML to the Defense Logistics Agency (DLA), a component of the U.S. Department of Defense (DoD). The contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, on September 24, 2021, with a ceiling value of $4,084.80. The contract is a Firm Fixed Price Delivery Order, and no set-aside designation was used. Amerisourcebergen Drug Corp is a subsidiary of the parent company, Cencora, Inc.,...
This federal contract award is for the delivery of pharmaceutical products, specifically NOVOLOG 100 UNIT/ML FLEXPEN 3ML, to the Defense Logistics Agency (DLA). The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an award value of $1,740.66 and a completion date of September 1, 2021. Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc., which holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical distributor Amerisourcebergen Corporation. The contract is a firm fixed price delivery order with a ceiling value of $1,838.16 and a performance period through April 11, 2024. Amerisourcebergen Drug Corp is also the prime contractor on a...
The federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA) Troop Support Medical. The prime contractor is Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, a leading global pharmaceutical sourcing and distribution services company. This is a firm fixed price delivery order contract with a potential value of $1,599.88, awarded by the DLA Troop Support Medical agency with a completion...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical products to the Defense Logistics Agency (DLA). The contract, valued at $1,738.17, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a Delivery Order with a Firm Fixed Price pricing type, and has an ultimate completion date of November 19, 2024. The contract is not associated with a set-aside designation,...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML medical supplies to the Defense Logistics Agency (DLA). The contract, valued at $5,407.96, was awarded to the prime contractor Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, and the ultimate completion date is January 7, 2025. The contract is not designated with a set-aside requirement, indicating open...
This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to the Defense Logistics Agency (DLA), a defense agency. The $1,073.54 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, on December 12, 2024, with a completion date of December 13, 2024. This award is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 that...
  • SPE2DB20D2104
    Indefinite Delivery Contract
  • SPE2DB20D2104-SPE2DB23FV23L
    Delivery Order

This federal contract award is for the delivery of NOVOLOG 100 UNIT/ML FLEXPEN 3ML pharmaceutical products to support federal government healthcare programs. The prime contractor is Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $3,572.12, was awarded by the Defense Logistics Agency (DLA) as a delivery order. It has an ultimate completion date of September 8, 2023.

Amerisourcebergen Drug Corp is a subsidiary of Cencora, Inc. and is registered in the System for Award Management (SAM.gov) through June 2025. The contract does not have a set-aside designation, indicating open competition. Amerisourcebergen Drug Corp also holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally.

Generated 2/27/25, 11:15 AM